Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma,unspecified: comparison with AILD,ALCL, lymphoblastic lymphoma,and ATLL |
| |
| Authors: | Tsuchiya Takeshi Ohshima Koichi Karube Kennosuke Yamaguchi Takahiro Suefuji Hiroaki Hamasaki Makoto Kawasaki Chika Suzumiya Junji Tomonaga Masao Kikuchi Masahiro |
| |
| Affiliation: | Department of Pathology and Internal Medicine, School of Medicine, Fukuoka University, Fukuoka, Japan. |
| |
| Abstract: | A new World Health Organization classification was recently proposed. However, classification of peripheral T-cell lymphomas remains to be clarified. Particularly, unspecified type was considered as a heterogeneous category. Here we studied the expressions of chemokine receptors, Th1-associated CXCR3 and CCR5 and Th2-associated marker ST2(L), and activated T-cell receptor OX40/CD134 in 185 patients with nodal T-cell lymphoma, and evaluated the relationship to prognosis. Their expression patterns correlated with the specific subtype of nodal T-cell lymphoma, such as angioimmunoblastic T-cell lymphoma (AILD), anaplastic large cell lymphoma (ALCL), and in peripheral T-cell lymphoma (PTCL), unspecified. In AILD, almost all cases were immunoreactive for OX40/CD134 (96%) and for CXCR3 (89%). In ALCL, all cases were immunonegative for OX40/CD134, and only a few cases (24%) were immunoreactive for CXCR3, whereas almost all cases (94%) were positive for ST2(L). Cases of PTCL, unspecified, were divided into 2 groups; group 1 (cases positive for either ST2(L), CCR5, or CXCR3) tended to show favorable prognosis compared with group 2 (cases negative for ST2(L), CCR5, and CXCR3). Our results indicate that further subtyping of PTCL, unspecified, into groups 1 and 2 could be significant for evaluating prognosis and understanding the functional role of these tumors. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
